SelectQuote, Inc. (New York Stock Exchange:SLQT)
| Market Cap | 63.77M-81.6% |
| Revenue (ttm) | 1.62B+6.0% |
| Net Income | 62.19M+30.7% |
| EPS | 0.35-140.3% |
| Shares Out | 176.35M |
| PE Ratio | 1.03 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 130,943 |
| Open | 0.36 |
| Previous Close | 0.37 |
| Day's Range | 0.36 - 0.37 |
| 52-Week Range | 0.36 - 2.22 |
| Beta | 1.69 |
| Analysts | Hold |
| Price Target | 3.13(+765.60%) |
| Earnings Date | Nov 5, 2026 |
Insiders here have filed 31 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About SLQT
SelectQuote, Inc. operates as a tech-driven, direct-to-consumer marketplace, offering a wide spectrum of insurance products to individuals throughout the United States. These policies are underwritten by a variety of insurance carriers. The company structures its operations across three core divisions: Senior, Life, and Auto & Home. Within its Senior segment, SelectQuote provides access to a comprehensive suite of health policies, including Medicare Advantage, Medicare Supplement, and Medicare Part D plans. This segment also features ancillary coverages such as prescription drug plans, dental, vision, and hearing benefits. The Life division concentrates on term life insurance offerings, while the Auto & Home segment delivers personal automobile, homeowners', and general casualty insurance solutions. Established in 1999, SelectQuote, Inc. is headquartered in Overland Park, Kansas.
$SLQT stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in SLQT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SLQT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SLQT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
SLQT Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Healthcare Services | $844.93M | 26.02% |
| Pharmacy | $830.85M | 25.59% |
| Commissions | $787.64M | 24.26% |
| Senior | $575.95M | 17.74% |
| Life | $186.04M | 5.73% |
| All other | $20.23M | 0.62% |
| Other services | $1.69M | 0.05% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-K)
U.S. Patents
New SLQT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SLQT from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in SLQT
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $2.39M |
| VXFVanguard Extended Market ETF | $946.35K |
| ALFAAlphaClone Alternative Alpha ETF | $431.83K |
| FESMFidelity Enhanced Small Cap ETF | $337.04K |
| SCHASchwab U.S. Small-Cap ETF | $289.01K |
| VFHVanguard Financials ETF | $133.27K |
Estimated from each fund’s disclosed top holdings × AUM
SLQT Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from SLQT’s recent data — informational, not investment advice